REFRACTORY ACUTE LEUKEMIA
Clinical trials for REFRACTORY ACUTE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY ACUTE LEUKEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY ACUTE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo shows promise for tough leukemia cases
Disease control OngoingThis study tests a combination of three drugs (chidamide, azacytidine, and a chemotherapy regimen called HAG) in adults aged 18 to 70 with acute myeloid leukemia that has come back or not responded to standard treatment. The goal is to see if this combination can shrink or elimin…
Matched conditions: REFRACTORY ACUTE LEUKEMIA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug shows promise for rare childhood cancers
Disease control OngoingThis study tests a drug called larotrectinib in children and young adults with certain cancers that have a specific genetic change called a TRK fusion. The goal is to see if the drug can shrink tumors or control the cancer. About 33 participants with solid tumors or relapsed leuk…
Matched conditions: REFRACTORY ACUTE LEUKEMIA
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 04, 2026 16:23 UTC